Cargando…
The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis
PURPOSE: The prognostic value of a new scoring system, termed F-NLR, that combines pretreatment fibrinogen level with neutrophil-lymphocyte ratio has been evaluated in various cancers. However, the results are controversial. The purpose of this study was to comprehensively analyze the prognostic val...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746466/ https://www.ncbi.nlm.nih.gov/pubmed/33376559 http://dx.doi.org/10.1155/2020/4565379 |
_version_ | 1783624804563156992 |
---|---|
author | Liu, Rongqiang Zheng, Shiyang Yuan, Qing Zhu, Peiwen Li, Biao Lin, Qi Shi, Wenqing Min, Youlan Ge, Qianmin Shao, Yi |
author_facet | Liu, Rongqiang Zheng, Shiyang Yuan, Qing Zhu, Peiwen Li, Biao Lin, Qi Shi, Wenqing Min, Youlan Ge, Qianmin Shao, Yi |
author_sort | Liu, Rongqiang |
collection | PubMed |
description | PURPOSE: The prognostic value of a new scoring system, termed F-NLR, that combines pretreatment fibrinogen level with neutrophil-lymphocyte ratio has been evaluated in various cancers. However, the results are controversial. The purpose of this study was to comprehensively analyze the prognostic value of F-NLR score in patients with cancers. METHODS: An integrated search of relevant studies was conducted by screening the PubMed and Embase databases. Pooled hazard ratios, with 95% confidence intervals (CIs), for overall survival (OS) and disease-free survival (DFS)/progression-free survival (PFS) were calculated to estimate the prognostic significance of F-NLR score in patients with various tumors. A random effects model was used for comprehensive analysis, and subgroup and meta-regression analyses were used to explore sources of heterogeneity. RESULTS: Thirteen articles reporting data from of 4747 patients were included in the study. Pooled analysis revealed that high F-NLR score was significantly associated with poor OS (HR = 1.77; 95% CI, 1.51–2.08) and poor DFS/PFS (HR = 1.63; 95% CI, 1.30–2.05). Subgroup and meta-regression analyses did not alter the prognostic role of F-NLR score in OS and DFS/PFS. CONCLUSIONS: Increased F-NLR score is significantly associated with poor prognosis in patients with cancers and can serve as an effective prognostic indicator. |
format | Online Article Text |
id | pubmed-7746466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-77464662020-12-28 The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis Liu, Rongqiang Zheng, Shiyang Yuan, Qing Zhu, Peiwen Li, Biao Lin, Qi Shi, Wenqing Min, Youlan Ge, Qianmin Shao, Yi Dis Markers Review Article PURPOSE: The prognostic value of a new scoring system, termed F-NLR, that combines pretreatment fibrinogen level with neutrophil-lymphocyte ratio has been evaluated in various cancers. However, the results are controversial. The purpose of this study was to comprehensively analyze the prognostic value of F-NLR score in patients with cancers. METHODS: An integrated search of relevant studies was conducted by screening the PubMed and Embase databases. Pooled hazard ratios, with 95% confidence intervals (CIs), for overall survival (OS) and disease-free survival (DFS)/progression-free survival (PFS) were calculated to estimate the prognostic significance of F-NLR score in patients with various tumors. A random effects model was used for comprehensive analysis, and subgroup and meta-regression analyses were used to explore sources of heterogeneity. RESULTS: Thirteen articles reporting data from of 4747 patients were included in the study. Pooled analysis revealed that high F-NLR score was significantly associated with poor OS (HR = 1.77; 95% CI, 1.51–2.08) and poor DFS/PFS (HR = 1.63; 95% CI, 1.30–2.05). Subgroup and meta-regression analyses did not alter the prognostic role of F-NLR score in OS and DFS/PFS. CONCLUSIONS: Increased F-NLR score is significantly associated with poor prognosis in patients with cancers and can serve as an effective prognostic indicator. Hindawi 2020-12-09 /pmc/articles/PMC7746466/ /pubmed/33376559 http://dx.doi.org/10.1155/2020/4565379 Text en Copyright © 2020 Rongqiang Liu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Liu, Rongqiang Zheng, Shiyang Yuan, Qing Zhu, Peiwen Li, Biao Lin, Qi Shi, Wenqing Min, Youlan Ge, Qianmin Shao, Yi The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis |
title | The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis |
title_full | The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis |
title_fullStr | The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis |
title_full_unstemmed | The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis |
title_short | The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis |
title_sort | prognostic significance of combined pretreatment fibrinogen and neutrophil-lymphocyte ratio in various cancers: a systematic review and meta-analysis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746466/ https://www.ncbi.nlm.nih.gov/pubmed/33376559 http://dx.doi.org/10.1155/2020/4565379 |
work_keys_str_mv | AT liurongqiang theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT zhengshiyang theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT yuanqing theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT zhupeiwen theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT libiao theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT linqi theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT shiwenqing theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT minyoulan theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT geqianmin theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT shaoyi theprognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT liurongqiang prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT zhengshiyang prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT yuanqing prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT zhupeiwen prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT libiao prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT linqi prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT shiwenqing prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT minyoulan prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT geqianmin prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis AT shaoyi prognosticsignificanceofcombinedpretreatmentfibrinogenandneutrophillymphocyteratioinvariouscancersasystematicreviewandmetaanalysis |